PHIO
Phio Pharmaceuticals Corp.
There isn't enough reported data to score PHIO yet.
PHIO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
PHIO's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
PHIO PE Valuation
PHIO has no meaningful PE right now: it lost money over the past year.
PHIO Forward outlook
There aren't enough analyst estimates for PHIO to show an outlook.
PHIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.21 | +$3.54 |
| Q2 2026 | -$1.29 | +$4.56 |
| Q1 2026 | -$1.38 | +$7.64 |
| Q4 2025 | -$1.45 | +$11.39 |
PHIO lost $1.21 per share over the past year, a smaller loss than the year before.
PHIO Quarterly Revenue
PHIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.3M | -$188K |
| Q2 2026 | -$4M | -$1.5M |
| Q1 2026 | -$4M | -$2.7M |
| Q4 2025 | -$2.1M | -$707K |
| Q3 2025 | -$2.1M | -$139K |
| Q1 2025 | -$1.3M | +$734K |
| Q4 2024 | -$1.4M | +$998K |
| Q3 2024 | -$2M | +$947K |
PHIO has burned cash in almost every quarter: −$12M over the past year, against −$7M the year before.
PHIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +72.7K shares |
| 1 year | +144% | +6.9M shares |
| 3 years | +9140% | +11.6M shares |
| 5 years | +25323% | +11.6M shares |
PHIO has 12M diluted shares, up 144% from a year ago.
PHIO Net Leverage
PHIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PHIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 8.6 | Oversold |
PHIO's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).
PHIO PE vs Healthcare Sector
PHIO has no meaningful PE right now: it lost money over the past year.
PHIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.90 | 10% below |
| 20 week MA | $0.99 | 18% below |
| 50 week MA | $1.08 | 25% below |
| 100 week MA | $1.52 | 47% below |
| 200 week MA | $9.05 | 91% below |
PHIO is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
PHIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $870.8 | $291.6 | -67% |
| 2021 | $291.6 | $127.4 | -56% |
| 2022 | $127.4 | $38.7 | -70% |
| 2023 | $38.7 | $6.84 | -82% |
| 2024 | $6.84 | $1.93 | -72% |
| 2025 | $1.93 | $1.08 | -44% |
| 2026 YTD | $1.08 | $0.81 | -25% |
PHIO has finished every year since 2020 lower, and it's down 25% so far in 2026.